Developing a first-in-class therapy for GRIN-NDD Radiprodil is in development as the first therapy designed to directly address the underlying biology of GRIN-related neurodevelopmental disorder.

https://www.drugdiscoverynews.com/developing-a-first-in-class-therapy-for-grin-ndd-16784?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz--gndxxi8gEUcc3gjy3M4BoKlGbUNEX1DDcLuiKrtYFj9-nAzYtAhtELMbLMO9PmA0CDwDS7mdAT-ftOhAXhwClkzaQBA&_hsmi=391788877&utm_content=391788877&utm_source=hs_email